Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anxioselective anxiolytics: can less be more?

Anthony S Basile1, Arnold S Lippa, Phil Skolnick

  • 1DOV Pharmaceutical, Inc., 433 Hackensack Avenue, Hackensack, NJ 07601, USA. abasile@dovpharm.com

European Journal of Pharmacology
|October 7, 2004
PubMed
Summary

New anxiolytic drugs targeting gamma-aminobutyric acid type A (GABA(A)) receptors aim for anxiety relief without the side effects of benzodiazepines. Research explores "anxioselective" compounds for improved treatment options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-marketing Surveillance of Intranasal Nalmefene: Prevalence and Clinical Relevance of Precipitated Withdrawal.

Cureus·2025
Same author

Reversal of a synthetic opioid overdose: Insights from a validated translational model.

Neuropharmacology·2025
Same author

Reproducibility of the Determination of <sup>13</sup>C-Labeling of Glutamate and Glutamine in the Human Brain Using selPOCE-MRS at 7 T Upon [U-<sup>13</sup>C]-Labeled Glucose Infusion.

NMR in biomedicine·2025
Same author

Translational Modeling as a Tool to Evaluate the Effectiveness of Nalmefene in a Community Setting: A Critical Perspective.

Clinical pharmacology and therapeutics·2025
Same author

Synthetic opioids have disrupted conventional wisdom for treating opioid overdose.

Drug and alcohol dependence reports·2024
Same author

Editorial: Discovery, development and implementation of improved options for treating opioid overdose in the synthetic opioid era.

Frontiers in psychiatry·2024

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Benzodiazepines are common anxiety disorder treatments.
  • They have significant side effects like sedation and abuse potential.

Purpose of the Study:

  • To review nonclinical and clinical studies of "anxioselective" anxiolytics.
  • To discuss mechanisms of GABA(A) receptor-targeted anxiolytics.

Main Methods:

  • Review of nonclinical and clinical studies.
  • Analysis of GABA(A) receptor modulation.

Main Results:

  • Development of GABA(A) receptor partial agonists and subtype-selective agents.
  • Exploration of compounds combining these features.

Related Experiment Videos

Conclusions:

  • Anxioselective anxiolytics offer potential efficacy without limiting side effects.
  • Targeting GABA(A) receptors may provide safer anxiety treatments.